Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-24-000420
Filing Date
2024-10-11
Accepted
2024-10-11 09:08:48
Documents
44
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 06-30-2024 form_10-q.htm   iXBRL 10-Q 655041
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 10233
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 10224
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 4998
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 4989
  Complete submission text file 0001161697-24-000420.txt   3534965

Data Files

Seq Description Document Type Size
6 INLINE XBRL SCHEMA FILE gstc-20240630.xsd EX-101.SCH 46694
7 INLINE XBRL CALCULATION FILE gstc-20240630_cal.xml EX-101.CAL 33303
8 INLINE XBRL DEFINITION FILE gstc-20240630_def.xml EX-101.DEF 129644
9 INLINE XBRL LABEL FILE gstc-20240630_lab.xml EX-101.LAB 299206
10 INLINE XBRL PRESENTATION FILE gstc-20240630_pre.xml EX-101.PRE 193314
47 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 417001
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 241366505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)